Delegates From European Parliament Express Support For Rapid Development Of New TB Vaccine
Emergent BioSolutions Inc. (NYSE:EBS) announced that a joint delegation of Members of the European Parliament (MEPs) and representatives from the Oxford-Emergent Tuberculosis Consortium (OETC) visited the trial site where MVA85A, the world’s most clinically advanced tuberculosis (TB) vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial. This clinical trial in Worcester, South Africa is being conducted by the University of Cape Town’s South African Tuberculosis Vaccine Initiative (SATVI), in partnership with OETC and Aeras.
Tuberculosis rates in Birmingham reach Third World levels
The Government is being urged to reconsider its policy on vaccinating all schoolchildren for tuberculosis (TB) as rates in Birmingham reach Third World levels.
Immunitor Presents Positive TB Treatment Data at African Conference
http://www.globenewswire.com/
Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2nd to 5th March, 2011.
TB Control Programme to be launched in rural areas
http://www.dailytimes.com.pk
Health care facilities under the National TB Control Programme would be provided at the 3 rural health centers of Islamabad while other rural health centers are to be upgraded shortly under 1st phase of the programme, said Deputy Commissioner (DC) Islamabad Amer Ali Ahmed on Tuesday.
Congo gets 17b from World Fund against HIV/AIDS, TB, malaria
http://www.afriquejet.com
The World Fund against HIV/AIDS, tuberculosis and malaria will grant 17 billion CFAF to Congo to fight against HIV/AIDS, the Committee of National Coordination of Projects
New Diagnostic Tool for Quick Identification of TB
Scientists have developed a new diagnostic tool to identify active tuberculosis more quickly and effectively.
Notre Dame researchers discover dual-action compound for potential treatment of TB and malaria
http://www.southbendtribune.com
Marvin Miller, the George and Winifred Clark Chair in Chemistry, and Michael Ferdig, associate professor of biological sciences at the University of Notre Dame, are co-authors of a study recently published in the Journal of the American Chemical Society on a potential breakthrough in the fight against tuberculosis and malaria.
A Century of Fighting TB
World TB Day commemorates Koch's announcement on March 24, 1882, that he had discovered the TB bacillus that causes the disease. WHO says TB was raging in Europe and the Americas at that time, causing the deaths of one in every seven people, and Koch's discovery "opened the way towards diagnosing and curing TB."
Koch, a German, died in 1910. But TB has not been eradicated in the century since he accepted the Nobel Prize in Physiology or Medicine in 1905 for his discovery.
Fighting tuberculosis in the North
Tuberculosis isn't a big problem in most of Canada. But as an editorial in the Canadian Medical Association Journal details, its incidence has reached epidemic levels in the North, and in particular, in Nunavut.
Efficacy Of Tuberculosis Vaccine Enhanced By VIB Scientists
http://www.medicalnewstoday.com
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
